New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
NYT > Science·September 30, 2026
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
